Aberrations of TACC1 and TACC3 are associated with ovarian cancer - Wikidata - awgldk - TriplyDB

Aberrations of TACC1 and TACC3 are associated with ovarian cancer

Aberrations of TACC1 and TACC3 are associated with ovarian cancer

http://www.wikidata.org/entity/Q24811001

about

FGFR3-TACC3 fusion in solid tumors: mini review Regulating the ARNT/TACC3 Axis: Multiple Approaches to Manipulating Protein/Protein Interactions with Small Molecules TACC3-ch-TOG track the growing tips of microtubules independently of clathrin and Aurora-A phosphorylation The transforming acidic coiled coil (TACC1) protein modulates the transcriptional activity of the nuclear receptors TR and RAR.TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer Glucocorticoid-induced reversal of interleukin-1β-stimulated inflammatory gene expression in human oviductal cells.Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes.Evidence for the importance of personalized molecular profiling in pancreatic cancer.The transforming acidic coiled coil 3 protein is essential for spindle-dependent chromosome alignment and mitotic survival.Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway.TACC3 is essential for EGF-mediated EMT in cervical cancer Impact of NPM, TFF3 and TACC1 on the prognosis of patients with primary gastric cancer.MoMuLV-ts-1: A Unique Mouse Model of Retrovirus-Induced Lymphoma Transmitted by Breast Milk.High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues.TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors A small compound targeting TACC3 revealed its different spatiotemporal contributions for spindle assembly in cancer cells.Regulation of paclitaxel activity by microtubule-associated proteins in cancer chemotherapy.The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program.The centrosomal adaptor TACC3 and the microtubule polymerase chTOG interact via defined C-terminal subdomains in an Aurora-A kinase-independent manner.Interaction of TACC proteins with the FHL family: implications for ERK signaling.TACC3 in personalized medicine TACC3 depletion sensitizes to paclitaxel-induced cell death and overrides p21WAF-mediated cell cycle arrest.TACC3 as an independent prognostic marker for solid tumors: a systematic review and meta-analysis.Repeats in transforming acidic coiled-coil (TACC) genes.TACC3 deregulates the DNA damage response and confers sensitivity to radiation and PARP inhibition.TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer.Disruption of Tacc3 function leads to in vivo tumor regression.Suppression of intestinal tumors by targeting the mitotic spindle of intestinal stem cells.Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.Prognosis significance of HER2 status and TACC1 expression in patients with gastric carcinoma.Downregulation of TACC3 inhibits tumor growth and migration in osteosarcoma cells through regulation of the NF-κB signaling pathway.Pretreatment TACC3 expression in locally advanced rectal cancer decreases the response to neoadjuvant chemoradiotherapy High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis

P2860

Q26740578-73C57A15-D9F1-4EA4-9297-AD7B00520D1C Q27675499-919D7E89-2751-479C-AE59-212202281252 Q29347519-B13633D5-BEC5-439B-A349-285DFFFCAB48 Q33524554-AF4C2E17-2ABD-462A-ACAB-E686F79518F6 Q33636574-1740B039-FE1B-44B7-9C3C-6737CDAE36EA Q33645478-67BF1E6A-F835-4D6D-8099-98A9AFD104D6 Q34152192-51CCB7E3-D4E8-4613-80DB-3D14F98CF5D0 Q34387784-E19BF01F-1C90-41A9-84D8-23F07DCA94D5 Q34659420-F058AFCB-BA24-4663-96AD-837AC6CFD865 Q34662199-4B158E86-CC96-4DCD-A0D6-50A6BAFEB31D Q34925509-FBE8B815-9446-4B69-8A10-25C723A2C3BE Q35072625-1CA3135A-3507-4255-AECF-2CAA571375C1 Q35692359-55D13C58-D98A-4022-8511-370B3B403A0D Q35740091-570C76FA-B596-4B0A-97B9-E3D1A7F8AAEC Q36410625-6C7C5328-1914-4755-9C7C-46A6D0F6A2CB Q36414408-25094E46-46B4-4B72-87E7-A77304530D0A Q37520384-F8179B1B-FD54-412C-AEBE-3B2103FC14CB Q37688959-78A6B47D-8F4C-4A36-AC3C-D03315BC5CCA Q39090181-2AC0F9EB-82B0-459E-9555-6746CF27176E Q39456292-17A439A3-7B4F-4201-B9E7-7FB387ED4BC1 Q39664652-04392A4B-70E0-43C9-B374-7752D77CD50D Q41848433-F37C43BC-1011-4B9F-82D8-1873F5346B3F Q41959511-25CF55C1-B178-467E-AE3B-447DBDE3B31D Q42087478-3372B10B-C811-45BF-BC43-CE1C69915630 Q42827040-2CC98AE9-D895-4361-9D56-83199738B3DF Q43050437-DE11285F-5D36-440A-BB99-9396967E3FC8 Q44283332-5FA9570B-5A3D-41C7-AFF0-5FD82E6A075D Q48314165-14C76A02-7489-4BB6-985A-61689AEE9760 Q49865845-A813235D-22B7-4498-BD01-66985E778E83 Q52612716-AF33BBB2-BB43-4D77-A118-99626455C374 Q52671384-1B419D1E-BC24-4ABB-BC74-B8300F007F62 Q53204532-BF153911-C1C3-4B60-98C2-0DC272C804AF Q54316753-F39E6388-3691-460D-876C-8792DC7D551E Q55077417-9A732E6D-2EA3-456F-859A-5B1F4E3B550B Q57809077-BB98A07A-C3D7-45E4-9886-E548571D3CBA Q58733699-AA971675-5D8E-4C84-82D4-08C0CA7E0A49

P2860

Aberrations of TACC1 and TACC3 are associated with ovarian cancer

http://www.wikidata.org/entity/Q24811001

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Aberrations of TACC1 and TACC3 are associated with ovarian cancer

@ast

Aberrations of TACC1 and TACC3 are associated with ovarian cancer

@en

Aberrations of TACC1 and TACC3 are associated with ovarian cancer

@nl

type

label

Aberrations of TACC1 and TACC3 are associated with ovarian cancer

@ast

Aberrations of TACC1 and TACC3 are associated with ovarian cancer

@en

Aberrations of TACC1 and TACC3 are associated with ovarian cancer

@nl

prefLabel

Aberrations of TACC1 and TACC3 are associated with ovarian cancer

@ast

Aberrations of TACC1 and TACC3 are associated with ovarian cancer

@en

Aberrations of TACC1 and TACC3 are associated with ovarian cancer

@nl

P1433

Q24811001-81E462E9-0968-4BA7-BD9F-29C6B3A9E01B

P1476

Q24811001-8F7494AD-7106-4BE1-A489-AD66401BAB8C

P2093

Q24811001-07618B7F-DAF8-4F72-9CE6-F87A1CAF4CA5

Q24811001-07B6EAEA-3D61-4E52-A127-A0C8E2308014

Q24811001-3E33EDBA-BC8C-418A-B904-8B09495AB4D7

Q24811001-6F5AC43B-5FD4-4B5C-A63C-5359BA41A246

Q24811001-98224047-7A8C-42FC-B288-FDEE0D09D7C5

Q24811001-C24D5130-7DA7-46B1-AA63-0C2CE95765CA

Q24811001-FB0269FA-6779-4850-AA2E-9BB9A58FFAAC

P2860

Q24811001-0910CDEC-8207-435B-A953-0E3B1100A83F

Q24811001-0B4CCA10-33E1-40E3-B70A-427B8A1E5ED2

Q24811001-11B293E4-7865-4453-B207-0FDF71C98174

Q24811001-13469C17-98F4-47FA-BDA3-5DB087F58094

Q24811001-1C33E14D-F590-4EBA-BC41-C0B7E4BA5D15

Q24811001-1ED07F86-6FE9-4F89-B459-F8882A372A71

Q24811001-25774453-E8CA-4D4A-83CD-64588DDFACFA

Q24811001-3693D3F2-51A2-4429-9073-700424FFCA76

Q24811001-377C88D9-4005-416C-A1C3-903474357E6C

Q24811001-3FF1CB3E-7816-4C2B-BFEB-78ED2CEF76F4

P2888

Q24811001-E355BCD9-AA28-4AD5-B782-2BA77D8DBB07

P304

Q24811001-C24BB758-2B31-4E0F-855C-49CC3515EF5A

P31

Q24811001-6F103F75-B250-4C44-BB0B-0061408121F4

P3181

Q24811001-B42A17EB-E793-4820-B766-ACED3314B367

P356

Q24811001-74E38B39-D821-446D-A2B5-6603A30C8A2F

P407

Q24811001-E919AD5A-2224-4952-806F-943917BBC251

P433

Q24811001-914811DA-81F3-40D2-9D19-9A73EFD6FC97

P478

Q24811001-5CDD8020-4524-49B4-A9D5-8BD9F97CFB24

P577

Q24811001-0FE9322D-B520-497C-B66E-5B8335E1D0A1

P5875

Q24811001-B61DF16B-32B5-40F3-88BB-31021CEA3FAE

P6179

Q24811001-A780BAA3-35D7-4CF0-9308-7145C8A2181A

P698

Q24811001-FC712499-ED2D-48C6-849A-420664045D5A

P921

Q24811001-106A1E5D-CDB5-4856-ADB2-9514A4939ED3

Q24811001-321A347A-0A12-46D6-8CFC-D9EDD88370D6

P932

Q24811001-4241962B-2E26-43FC-AB06-35544B728005

P3181

P356

P1433

BMC Women's Health

P1476

Aberrations of TACC1 and TACC3 are associated with ovarian cancer

@en

P2093

Brenda Lauffart

http://www.w3.org/2001/XMLSchema#string

David Chervinsky

http://www.w3.org/2001/XMLSchema#string

Ivan H Still

http://www.w3.org/2001/XMLSchema#string

Jennifer D Black

http://www.w3.org/2001/XMLSchema#string

Mary M Vaughan

http://www.w3.org/2001/XMLSchema#string

Richard A DiCioccio

http://www.w3.org/2001/XMLSchema#string

Roger Eddy

http://www.w3.org/2001/XMLSchema#string

P2860

Structure-function evolution of the transforming acidic coiled coil genes revealed by analysis of phylogenetically diverse organisms

Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators

The centrosomal protein TACC3 is essential for hematopoietic stem cell function and genetically interfaces with p53-regulated apoptosis

AZU-1: a candidate breast tumor suppressor and biomarker for tumor progression

The TACC domain identifies a family of centrosomal proteins that can interact with microtubules

Serial analysis of gene expression

Ovarian surface epithelium: biology, endocrinology, and pathology

Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers

Isolation and characterization of AINT: a novel ARNT interacting protein expressed during murine embryonic development

Altered splicing pattern of TACC1 mRNA in gastric cancer.

P2888

P304

8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4816210

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1472-6874-5-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7822683

http://www.w3.org/2001/XMLSchema#string

P6179

1050834291

http://www.w3.org/2001/XMLSchema#string

P698

15918899

http://www.w3.org/2001/XMLSchema#string

P921

obstetrics and gynaecology

P932

1175095

http://www.w3.org/2001/XMLSchema#string